EQS-News: leon-nanodrugs appoints Dr. Hans Frickel as Chief Executive Officer
July 18, 2023 – Munich (Germany) – leon-nanodrugs GmbH (“LEON”), the leading enabler of nano technology for the pharmaceutical industry, announced today the appointment of Dr. Hans Frickel as CEO, effective July 1, 2023.
- July 18, 2023 – Munich (Germany) – leon-nanodrugs GmbH (“LEON”), the leading enabler of nano technology for the pharmaceutical industry, announced today the appointment of Dr. Hans Frickel as CEO, effective July 1, 2023.
- Dr. Hans Frickel, a trained pharmacist and industrial manager, brings more than 20 years of experience in strategic and operational leadership roles across the entire value chain of pharmaceuticals and medical devices.
- Dr. Hubert Birner, Chairman of the LEON Supervisory Board, said: “On behalf of the Supervisory Board, I am delighted to welcome Dr. Hans Frickel to LEON.
- “I am impressed with the team’s knowledge and dedication in working to create added value across the nano formulation processing chain.